ABSTRACT
Site‐specific labeling of RNA with emissive, structurally non‐perturbing nucleosides is critically needed for probing RNA structure, dynamics, and function. Isothiazolopyrimidine‐based nucleoside surrogates are leading examples of fluorescent RNA building blocks, with the C‐nucleosidic guanosine analogue tzG standing out due to its brightness. Here, we report the first synthesis of a tzG phosphoramidite and its incorporation into RNA via solid‐phase synthesis. Comprehensive biochemical and photophysical analyses demonstrate that tzG acts as an isomorphic and isofunctional substitute for guanosine, with fluorescence properties that are sensitive to local environmental changes. These features enable fluorescence‐based monitoring of RNA cleavage by deoxyribozymes and of site‐specific RNA methylation by a methyltransferase ribozyme. Our findings establish tzG as a valuable emissive nucleoside analog for the interrogation of RNA modifications at defined positions.
Keywords: fluorescent probes, ribozymes, tRNA
The emissive isothiazologuanosine analog tzG is synthesized for the first time as RNA phosphoramidite building block for solid‐phase synthesis. Due to its isomorphic and isofunctional characteristics, tzG forms Watson–Crick base pairs and can be used as fluorescent probe to monitor (deoxy)ribozyme activity.

1. Introduction
Fluorescence‐based tools are crucial for modern biophysical studies of structure, function, and interplay of biopolymers, as well as small molecule cofactors and messengers [1, 2, 3]. While proteins naturally contain intrinsically fluorescent amino acids, such as tryptophane, canonical RNA and DNA nucleotides are inherently non‐emissive due to fast non‐radiative decay pathways, resulting in short excited‐state lifetimes and negligible fluorescence quantum yields [4, 5]. To overcome this limitation, the development of artificial fluorescent nucleotides has become essential for probing fundamental biochemical processes and enabling the development of biophysical assays. Conventional labeling strategies often rely on bulky exogenous fluorophores that can induce structural perturbations, alter folding dynamics and disrupt functional interactions. Moreover, many existing probes lack environmental sensitivity, limiting their utility for reporting local conformational changes or molecular interactions [6]. Emissive environment‐responsive nucleobase surrogates that mimic the size, structure and function of their native counterparts are needed to overcome these challenges. Alongside 2‐aminopurine (2AP), reported by Stryer in 1969 [7], a large number of base‐pairing, emissive nucleoside analogs including 5‐aryl pyrimidines [8, 9, 10, 11], 8‐furano‐ [9] and 8‐vinyl‐modified purines [12, 13, 14], 6‐aza‐pyrimidines [15, 16], quinazoline derivatives [17, 18] as well as bi‐ [19, 20, 21], tri‐ [22, 23, 24, 25, 26], and tetracyclic [27, 28, 29, 30] nucleobase analogs have been reported. In addition, the emissive RNA alphabet established by the Tor group in 2011 comprises highly fluorescent purines (thA, thG) and pyrimidines (thC, thU) based on a thieno[3,4‐d]pyrimidine heterocyclic core [31].
These isomorphic thN nucleotides have been used for a variety of applications including studies on small molecule cofactors, coenzymes and second messengers [32, 33, 34], monitoring translation [35], PCR labeling of long DNAs [36], transcription [37, 38, 39], structural investigations [40, 41, 42], and fluorescence‐based deamination assays [43, 44]. In the second generation emissive RNA alphabet, the nitrogen atom at the Hoogsteen edge was restored, yielding the isothiazolo[4,3‐d]pyrimidine skeleton (Figure 1) [45, 46]. The emissive tzN nucleosides are excellent substrates for metabolic and catabolic enzymes, allowing real‐time monitoring of enzymatic activity by fluorescence [47, 48, 49, 50]. Their microenvironmental responsiveness motivate applications of tzN nucleosides in oligonucleotides, but the synthetic accessibility of tzN‐modified RNA has been severely limiting their widespread use. Until today, the only two reported tzN‐containing RNAs have been enzymatically synthesized using excess of free tzG nucleoside for transcription initiation with a T7 polymerase mutant, followed by enzymatic ligation [51]. However, for the direct site‐specific installation of modified nucleotides, chemical oligonucleotide synthesis is often the method of choice. Here, we report the first synthetic route toward the tzG phosphoramidite and its incorporation into RNA by solid‐phase synthesis, providing convenient access to site‐specifically tzG‐modified RNA. We prepared several hairpin and duplex RNA constructs to explore the response of tzG to different base‐pairing partners in terms of thermal stability and photophysical response. Furthermore, we explored tzG‐modified RNAs as substrates for ribozymes and deoxyribozymes, and found that tzG fluorescence is a useful reporter of DNA‐catalyzed RNA‐cleavage by the 8–17 deoxyribozyme as well as RNA‐catalyzed RNA methylation by the MTR1 ribozyme.
FIGURE 1.

(a) Replacement of the purine scaffold in G with an isothiazolo[4,3‐d]pyrimidine heterocyclic core provides the emissive tzG nucleoside. (b) Excitation and emission spectra of rG (grey, insert) and tzG (blue).
2. Results and Discussion
The tzG phosphoramidite required for solid‐phase synthesis was prepared via a 16‐step synthetic route including carbon–carbon glycosidic bond formation. First, the free tzG nucleoside was synthesized as reported by the Tor lab [46]. Briefly, synthesis started with acetyl‐ and benzyl‐protection of d‐ribose, followed by Swern oxidation to give the ribonolactone precursor (Scheme S1). This precursor was subjected to alkylation via lithium–halogen exchange and further converted into the free thiol. Thorpe–Ziegler cyclization, stereoselective reduction and guanidinylation prior to deprotection of the exocyclic amine and the sugar hydroxy groups furnished the tzG nucleoside.
Nucleoside incorporation into RNA by solid‐phase synthesis requires orthogonal acid‐, base‐, and fluoride‐labile protecting groups on the nucleobase and ribose. In the first step, a dimethyl formamidine protecting group was installed at the exocyclic amino group of the tzG nucleobase (Scheme 1). This imine group can be cleaved under mildly basic conditions, in contrast to other commonly used nucleobase protection groups (e.g., acetyl and isobutyryl) which require harsher deprotection schemes that could degrade tzG. Next, the base‐protected tzG nucleoside was reacted with 4,4'‐dimethoxytrityl chloride to give the 5'‐DMT‐protected precursor 1.
SCHEME 1.

Synthesis of the tzG phosphoramidite building block 4. Reagents and conditions: (i) Dimethylformamide dimethyl acetal, MeOH, rt, 16 h, 71%. (ii) Dimethylformamide dimethyl acetal, pyridine, rt, 16 h, then DMT‐Cl, pyridine, rt, 16 h, 65%. (iii) TBDMS‐Cl, AgNO3, pyridine, rt, 16 h, 60% (2+3). (iv) NEt3, MeOH, rt, 30 min. (v) 2‐Cyanoethyl N,N‐diisopropylchlorphosphoramidit, Hünig's base, DCM, rt, 5 h, 65%.
The most critical step was protection of the 2'‐hydroxyl group. The majority of RNA building blocks used for solid‐phase synthesis are equipped with either a fluoride‐labile TBDMS or TOM group at the 2'‐OH. Upon reaction with the respective silylation reagent both the 2'‐ and the 3'‐protected isomers are formed and need to be separated. Since TBDMS‐protection, in contrast to TOM‐protection, proceeds at ambient temperature and the undesired 3'‐isomer 2 can be converted into the required 2'‐isomer 3 under basic conditions, TBDMS‐ was favored over TOM‐protection. The pure 2'‐protected nucleoside 3 was obtained after several column chromatographic purification steps. Finally, 3 was converted into the phosphoramidite 4 using 2‐cyanoethyl N,N‐diisopropylchlorophosphor‐amidite in the presence of Hünig's base (see Supporting Information (SI)).
The tzG phosphoramidite 4 was incorporated into the anticodon stemloop of human cytosolic tRNAAla(AGC) (R1 unmodified, R2 with tzG, Figure 2a) and the 5'‐fragment of mitochondrial tRNATrp (R9 unmodified, R10 with tzG, Figure S1 and Table S1) by solid‐phase synthesis. Deprotection by overnight incubation in aq. ammonia at 37°C followed by cleavage of the 2'‐silyl groups with TBAF furnished the deprotected RNA, which was purified by PAGE. HPLC chromatograms and HR‐ESI‐MS data for all synthesized RNAs are given in Figures S2, S3, and Table S1.
FIGURE 2.

(a) Sequence of the synthesized tzG‐modified RNA (tzG shown in bold) with the corresponding anion exchange HPLC chromatogram and the simulated and deconvoluted HR‐ESI mass spectrum. (b) Thermal denaturation analysis for melting temperatures T m of 2 µm unmodified (R1) and tzG‐modified hairpin (R2) and duplex samples in PBS with an estimated error of 0.5°C. ΔT is the melting temperature difference between unmodified and modified sample. See Table S1 for RNA sequences. (c) Fluorescence excitation and emission spectra for tzG‐containing RNA duplexes (consisting of R2 and R3–R8, see Table S2), the tzG‐modified hairpin R1 and the free tzG nucleoside tzGnuc (left) with the integrated emission intensity for each sample (right). (d) Relative quantum yield analysis with the integrated fluorescence intensity plotted versus the absorption factor a and (e) fluorescence lifetimes for duplexes with tzG opposite C or G in comparison with the tzG nucleoside and tzG in the hairpin. Detailed measurement conditions are given in the Supporting Information.
To evaluate the influence of tzG on hairpin and duplex stability, we compared unmodified (R1) and modified (R2) RNAs as mono‐ or bimolecular constructs upon hybridization with complementary oligonucleotides R3–R8 (containing A, C, G, U, I or acyclic spacer (C3) at position X, opposite the G/tzG position in R1/R2; Figure 2b). Duplex formation was demonstrated by native PAGE (Figure S4) and thermal stability was analyzed by UV absorbance. The melting curve of the monomolecular hairpin conformation showed that incorporation of tzG into the anticodon loop decreases the melting temperature by only ΔT m = –0.3°C compared to the unmodified variant (Figures 2b, S5, and Table S2) [52]. When implemented into 18‐mer duplex structures tzG slightly elevates stability (ΔT m = +0.5 to +2.1°C) compared to the unmodified rG‐containing oligonucleotides. The highest thermal stability with T m = 72.5°C is observed for the tzG|C base paired duplex. When tzG is placed opposite sterically more demanding purines or the flexible acyclic propyl linker (C3), the resulting duplex structures are thermally less stable compared to pyrimidines. Overall, these thermal analyses support the isomorphic character of tzG as it forms a Watson–Crick base pair with C and is well accommodated in both hairpin and duplex RNA structures. These observations are in accordance with reported results for thG‐modified oligonucleotides [31, 40] and predictions by theoretical calculations for tzG [53].
Next, we evaluated the fluorescence of tzG in RNA and its sensitivity toward microenvironmental changes. While many reported fluorescent nucleobase analogs experience quenching after incorporation into oligonucleotides, the emission intensity of the tzG‐modified anticodon stem loop is comparable to that of the free nucleoside (Figure 2c). Upon formation of the tzG|C Watson–Crick and tzG:U wobble base pair, emission is further enhanced by a factor of 1.7. Incorporation of adenosine (A), inosine (I) or a linear alkyl [(CH2)3] group opposite tzG leads to reduced fluorescence by 50%, likely caused by the increased steric demands of purine nucleobases or the higher flexibility of the acyclic propyl linker. The sterically demanding nucleobase partners can favor non‐radiative decay pathways as crowding promotes excited state distortions and facilitates access to conical intersections, thereby accelerating internal conversion processes and suppressing fluorescence [54]. If tzG is positioned opposite G, its fluorescence is significantly quenched to only 15% of the emission intensity of the brightest tzG:U pairing, likely due to redox‐based quenching mechanisms established for guanine [55]. These observations are also reflected in the emission quantum yield (Φ) which increases from 0.25 for the free tzG nucleoside to 0.39 for the tzG|C basepair and is lowest for tzG opposite G with only 0.08 (Figures 2d, S6, and Table S3). These results are in contrast to reported thG‐modified RNA oligonucleotides for which the fluorescence intensity increases with U < A < C < G as opposite nucleobase [31]. This effect might be caused not only by the distinct electronic structures and frontier orbital energies of thG and tzG, but also by structural and environmental effects such as the flanking nucleobases, the sequence context and duplex folding as reported for thG‐containing oligonucleotides (Figure S7 and Table S4) [40, 56]. Fluorescence lifetime analyses by time‐correlated single photon counting (TCSPC) further underline the high responsiveness of tzG to different base pairing partners (Figures 2e and S8). The excited state lifetimes (τ) for the tzG nucleoside and tzG in the stemloop are 8.1 and 9.4 ns, respectively, which matches well with a previously determined value for the free nucleoside [57]. Placing tzG opposite C or G in the duplex leads to either a significant increase to 13.3 ns in the case of C or decrease to 4.2 ns for G (Table S3).
These results suggest that tzG‐modified RNA constructs can be used to monitor the catalytic activity of ribozymes and deoxyribozymes by fluorescence spectroscopy. For example, modulating the environment of tzG upon site‐specific RNA‐cleavage or by alkylation of a neighboring nucleoside would be expected to result in detectable photophysical changes.
As a proof of principle for DNAzymes, we chose the 8–17 deoxyribozyme which cleaves RNA site‐specifically between two purine nucleosides [58, 59]. We designed three variants of 8–17 (D1–D3) with the binding arms adjusted for cleavage of the phosphodiester bond 5' of G in R1 and R9, or 3' of G in R9, respectively (Figures 3a and S9). First, we tested if replacement of G by tzG at the cleavage site (i.e., R2 and R10, respectively) is accepted in the DNA‐catalyzed transesterification. All three tested 8–17 DNAzymes produced the expected RNA fragments, demonstrating that tzG is indeed a functional mimic of G (Figures S10–S12 and Table S5). Using Mg2+ and Mn2+ as cofactors at pH 7.5 or 8.0, the unmodified RNAs were generally cleaved faster than the tzG RNAs (e.g. 1.7‐fold difference in k obs (Figure 3b) or larger differences for other buffer conditions (Table S5). Importantly, the fidelity of the cleavage site was maintained, which is essential for fluorescence‐based monitoring of RNA cleavage.
FIGURE 3.

(a) Schematic representation of the cleavage of R1/R2 and R9/R10 by 8–17‐deoxyribozyme variants D1 and D3 with the modified G shown in bold. (b) PAGE analysis and kinetic plot for cleavage of R9/R10 at 25°C. (c, d) Time‐dependent emission spectra and integrated emission intensity (insert) of R2 (c) and R10 (d) at 37°C. Conditions for kinetics: 1 µm RNA, 10 µm DNA, 50 mm Tris‐HCl, 150 mm NaCl, 10 mm MgCl2, and 10 mm MnCl2.
Indeed, for both R2 and R10, that is, cleavage 3' and 5' of tzG, a time‐dependent change in fluorescence emission was observed upon incubation with the respective 8–17 DNAzymes D1 and D3 and divalent metal ion cofactors (Figure 3c). Surprisingly, D1 resulted in decrease of fluorescence emission for R2, while D3 produced an increase in intensity for R10. These results can be rationalized by changes in the local environment and are consistent with the fluorescence properties described above (Figure 2). For R10, cleavage by D3 leads to separation between tzG and the quenching G residue, thus fluorescence enhancement is observed. On the other hand, in the complex of R2 and D1, tzG is situated in a highly fluorescent tzG:T wobble pair, which is disrupted upon cleavage‐mediated release of the short fragment. We note, however, that alternative explanations exist, since fluorescence is not only affected by the hybridization state and nucleotide environment, but also by buffer conditions and metal ions. Indeed, tzG fluorescence is sensitive to various divalent metal ions (Figure S13). While Mg2+ and Ca2+ ions barely impact emission, Mn2+ causes significant quenching (ca. 50% of the initial intensity), and Co2+ and Cu2+ cations almost completely abolish emission. In contrast, fluorescence before and after cleavage can be enhanced by denaturation in the presence of 80% formamide (Figure S14). Overall, our data shows that tzG is a suitable fluorescence reporter for the catalytic activity of the 8–17 deoxyribozyme with various RNAs.
Given the environmental sensitivity of tzG's photophysics, we hypothesize that it may be able to monitor postsynthetic RNA modifications at a neighboring position. Building on the promising results seen for DNA‐catalyzed RNA cleavage, we explored the potential of tzG to monitor RNA alkylation by the MTR1 ribozyme, which uses O 6‐alkylated guanine cofactors and transfers the alkyl moiety to N1 of a defined bulged adenosine (Figure 4a,b) [60, 61].
FIGURE 4.

(a) Schematic representation of MTR1 hybridized to R9/R10 substrate RNA. The G position replaced by tzG is shown in bold. (b) MTR1 catalyzes the transfer of an alkyl group from O 6‐alkylated guanine to N1 of adenosine. (c) Anion exchange HPLC analysis of RNA alkylation with MTR1 and Bn6G. 35 µm RNA R9 or R10 were incubated with 45 µm MTR1 and 200 µm Bn6G at pH6.0 for 16 h. (d) Excitation and emission spectra for 1 µm R10 in PBS pH7.4, with A or m1A next to tzG.
An RNA fragment of human mt‐tRNATyr, which naturally contains m1A at position A9, was chosen (Figure S1). PAGE and HPLC analyses show the unmodified RNA substrates R9 and the tzG‐containing R10 can be both methylated or benzylated using m6G or Bn6G, respectively, at N1 of the desired adenosine (Figures 4c and S15). Alkylation leads to an increase in tzG emission by up to 70%, either caused by changes in the base‐stacking geometry upon alkylation or reduced photoinduced electron transfer from alkylated adenine to excited tzG (Figures 4d and S15). Therefore, tzG can indeed be used as a fluorescent probe to monitor ribozyme‐mediated RNA alkylation. More broadly, our results demonstrate not only that MTR1 tolerates tzG‐modified RNA as a substrate but also suggest that tzG may be more generally applicable as a sensor for chemoenzymatic RNA modification.
3. Conclusion
In conclusion, tzG, an isomorphic and isofunctional G surrogate, has been synthesized and converted into its phosphoramidite and, for the first time, incorporated into RNA by solid‐phase synthesis. Thermal denaturation experiments demonstrate that tzG resembles G in its base pairing behavior while photophysical studies on matched and mismatched tzG‐containing duplexes underline the strong environmental sensitivity of this emissive nucleoside analog. This photophysical feature facilitates fluorescence‐based monitoring of deoxyribozyme‐mediated RNA cleavage and ribozyme‐catalyzed RNA alkylation. This work thus solves the long‐standing challenge of directly accessing site‐specifically modified tzG‐containing RNAs for structural and mechanistic studies of natural or artificial proteins and enzymes or as potential metal ion sensors.
Author Contributions
Julia Dietzsch: investigation, writing – original draft, conceptualization. Yitzhak Tor: writing – review and editing, supervision. Claudia Höbartner: supervision, writing – review and editing.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
The authors have cited additional references within the Supporting Information [62, 63, 64, 65, 66, 67, 68, 69].Supporting File: anie74695‐sup‐0001‐SuppMat.docx.
Acknowledgments
We thank Kfir Steinbuch for advice regarding tzG nucleoside synthesis, Florian Seitz for help with theoretical calculations and Michaela Schraut for ESI‐MS analysis of oligonucleotides. The project was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the Walter‐Benjamin‐Program (project number 515772064 to J.D.) and the National Institutes of Health (via GM 139407 to Y.T.).
Open access funding enabled and organized by Projekt DEAL.
Data Availability Statement
The data that supports the findings of this study are available in the Supporting information of this article.
References
- 1. Rodriguez E. A., Campbell R. E., Lin J. Y., et al., “The Growing and Glowing Toolbox of Fluorescent and Photoactive Proteins,” Trends in Biochemical Sciences 42 (2017): 111–129, 10.1016/j.tibs.2016.09.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Xu W., Chan K. M., and Kool E. T., “Fluorescent Nucleobases as Tools for Studying DNA and RNA,” Nature Chemistry 9 (2017): 1043–1055, 10.1038/nchem.2859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Wang M., Da Y., and Tian Y., “Fluorescent Proteins and Genetically Encoded Biosensors,” Chemical Society Reviews 52 (2023): 1189–1214, 10.1039/D2CS00419D. [DOI] [PubMed] [Google Scholar]
- 4. Daniels M. and Hauswirth W., “Fluorescence of the Purine and Pyrimidine Bases of the Nucleic Acids in Neutral Aqueous Solution at 300° K,” Science 171 (1971): 675–677, 10.1126/science.171.3972.675. [DOI] [PubMed] [Google Scholar]
- 5. Gustavsson T. and Markovitsi D., “Fundamentals of the Intrinsic DNA Fluorescence,” Accounts of Chemical Research 54 (2021): 1226–1235, 10.1021/acs.accounts.0c00603. [DOI] [PubMed] [Google Scholar]
- 6. Kloecker N., Weissenboeck F. P., and Rentmeister A., “Covalent Labeling of Nucleic Acids,” Chemical Society Reviews 49 (2020): 8749–8773, 10.1039/D0CS00600A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Ward D. C., Reich E., and Stryer L., “Fluorescence Studies of Nucleotides and Polynucleotides: I. Formycin, 2‐Aminopurine Riboside, 2,6‐Diaminopurine Riboside, and Their Derivatives,” Journal of Biological Chemistry 244 (1969): 1228–1237, 10.1016/S0021-9258(18)91833-8. [DOI] [PubMed] [Google Scholar]
- 8. Greco N. J. and Tor Y., “Simple Fluorescent Pyrimidine Analogues Detect the Presence of DNA Abasic Sites,” Journal of the American Chemical Society 127 (2005): 10784–10785, 10.1021/ja052000a. [DOI] [PubMed] [Google Scholar]
- 9. Greco N. J. and Tor Y., “Furan Decorated Nucleoside Analogues as Fluorescent Probes: Synthesis, Photophysical Evaluation and Site‐Specific Incorporation,” Tetrahedron 63 (2007): 3515–3527, 10.1016/j.tet.2007.01.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Greco N. J., Sinkeldam R. W., and Tor Y., “An Emissive C Analog Distinguishes Between G, 8‐oxoG, and T,” Organic Letters 11 (2009): 1115, 10.1021/ol802656n. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Srivatsan S. G. and Tor Y., “Fluorescent Pyrimidine Ribonucleotide: Synthesis, Enzymatic Incorporation, and Utilization,” Journal of the American Chemical Society 129 (2007): 2044–2053, 10.1021/ja066455r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Ben Gaied N., Glasser N., Ramalanjaona N., et al., “8‐Vinyl‐deoxyadenosine, an Alternative Fluorescent Nucleoside Analog to 2'‐Deoxyribosyl‐2‐aminopurine With Improved Properties,” Nucleic Acids Research 33 (2005): 1031–1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Nadler A., Strohmeier J., and Diederichsen U., “8‐Vinyl‐2'‐deoxyguanosine as a Fluorescent 2'‐deoxyguanosine Mimic for Investigating DNA Hybridization and Topology,” Angewandte Chemie International Edition 50 (2011): 5392–5396, 10.1002/anie.201100078. [DOI] [PubMed] [Google Scholar]
- 14. Muellar S., Strohmeier J., and Diederichsen U., “8‐Vinylguanine Nucleo Amino Acid: A Fluorescent PNA Building Block,” Organic Letters 14 (2012): 1382–1385, 10.1021/ol3000603. [DOI] [PubMed] [Google Scholar]
- 15. Sinkeldam R. W., Hopkins P. A., and Tor Y., “Modified 6‐Aza Uridines: Highly Emissive pH‐Sensitive Fluorescent Nucleosides,” ChemPhysChem 13 (2012): 3350–3356, 10.1002/cphc.201200375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Hopkins P. A., Sinkeldam R. W., and Tor Y., “Visibly Emissive and Responsive Extended 6‐Aza‐uridines,” Organic Letters 16 (2014): 5290–5293, 10.1021/ol502435d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Karimi A., Borner R., Mata G., and Luedtke N. W., “A Highly Fluorescent Nucleobase Molecular Rotor,” Journal of the American Chemical Society 142 (2020): 14422–14426, 10.1021/jacs.0c05180. [DOI] [PubMed] [Google Scholar]
- 18. Karimi A., Wang K., Basran K., Copp W., and Luedtke N. W., “A Bright and Ionizable Cytosine Mimic for i‐Motif Structures,” Bioconjugate Chemistry 34 (2023): 972–976, 10.1021/acs.bioconjchem.3c00055. [DOI] [PubMed] [Google Scholar]
- 19. Tinsley R. A. and Walter N. G., “Pyrrolo‐C as a Fluorescent Probe for Monitoring RNA Secondary Structure Formation,” RNA 12 (2006): 522–529, 10.1261/rna.2165806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Kotandeniya D., Rogers M. S., Fernandez J., et al., “6‐Phenylpyrrolocytosine as a Fluorescent Probe to Examine Nucleotide Flipping Catalyzed by a DNA Repair Protein,” Biopolymers 112 (2021): e23405, 10.1002/bip.23405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Hernandez A. R. and Kool E. T., “The Components of xRNA: Synthesis and Fluorescence of a Full Genetic Set of Size‐Expanded Ribonucleosides,” Organic Letters 13 (2011): 676–679, 10.1021/ol102915f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Lin K.‐Y., Jones R. J., and Matteucci M., “Tricyclic 2'‐Deoxycytidine Analogs: Syntheses and Incorporation Into Oligodeoxynucleotides Which Have Enhanced Binding to Complementary RNA,” Journal of the American Chemical Society 117 (1995): 3873–3874, 10.1021/ja00118a026. [DOI] [Google Scholar]
- 23. Sandin P., Borjesson K., Li H., et al., “Characterization and Use of an Unprecedentedly Bright and Structurally Non‐Perturbing Fluorescent DNA Base Analogue,” Nucleic Acids Research 36 (2008): 157–167, 10.1093/nar/gkm1006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Okamoto A., Tainaka K., and Saito I., “Clear Distinction of Purine Bases on the Complementary Strand by a Fluorescence Change of a Novel Fluorescent Nucleoside,” Journal of the American Chemical Society 125 (2003): 4972–4973, 10.1021/ja034090u. [DOI] [PubMed] [Google Scholar]
- 25. Burns D. D., Teppang K. L., Lee R. W., Lokensgard M. E., and Purse B. W., “Fluorescence Turn‐On Sensing of DNA Duplex Formation by a Tricyclic Cytidine Analogue,” Journal of the American Chemical Society 139 (2017): 1372–1375, 10.1021/jacs.6b10410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Samaan G. N., Wyllie M. K., Cizmic J. M., et al., “Single‐Molecule Fluorescence Detection of a Tricyclic Nucleoside Analogue,” Chemical Science 12 (2020): 2623–2628, 10.1039/D0SC03903A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Dierckx A., Miannay F. A., Ben Gaied N., et al., “Quadracyclic Adenine: A Non‐Perturbing Fluorescent Adenine Analogue,” Chemistry 18 (2012): 5987–5997, 10.1002/chem.201103419. [DOI] [PubMed] [Google Scholar]
- 28. Del Nogal A. W., Fuchtbauer A. F., Bood M., et al., “Getting DNA and RNA Out of the Dark With 2CNqA: A Bright Adenine Analogue and Interbase FRET Donor,” Nucleic Acids Research 48 (2020): 7640–7652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Le H. N., Kuchlyan J., Baladi T., Albinsson B., Dahlen A., and Wilhelmsson L. M., “Synthesis and Photophysical Characterization of a pH‐Sensitive Quadracyclic Uridine (qU) Analogue,” Chemistry 30 (2024): e202303539, 10.1002/chem.202303539. [DOI] [PubMed] [Google Scholar]
- 30. Okamoto A., Tanaka K., Fukuta T., and Saito I., “Cytosine Detection by a Fluorescein‐Labeled Probe Containing Base‐Discriminating Fluorescent Nucleobase,” ChemBioChem 5 (2004): 958–963, 10.1002/cbic.200400010. [DOI] [PubMed] [Google Scholar]
- 31. Shin D., Sinkeldam R. W., and Tor Y., “Emissive RNA Alphabet,” Journal of the American Chemical Society 133 (2011): 14912–14915, 10.1021/ja206095a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Li Y., Ludford P. T. 3rd, Fin A., Rovira A. R., and Tor Y., “Enzymatic Syntheses and Applications of Fluorescent Cyclic Dinucleotides,” Chemistry 26 (2020): 6076–6084, 10.1002/chem.202001194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Li Y., Fin A., Rovira A. R., et al., “Tuning the Innate Immune Response to Cyclic Dinucleotides by Using Atomic Mutagenesis,” ChemBioChem 21 (2020): 2595–2598, 10.1002/cbic.202000162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Vranken C., Fin A., Tufar P., Hofkens J., Burkart M. D., and Tor Y., “Chemoenzymatic Synthesis and Utilization of a SAM Analog With an Isomorphic Nucleobase,” Organic & Biomolecular Chemistry 14 (2016): 6189–6192, 10.1039/C6OB00844E. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Liu W., Shin D., Tor Y., and Cooperman B. S., “Monitoring Translation With Modified mRNAs Strategically Labeled With Isomorphic Fluorescent Guanosine Mimetics,” ACS Chemical Biology 8 (2013): 2017–2023, 10.1021/cb400256h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Otomo H., Park S., Yamamoto S., and Sugiyama H., “Amplification of Fluorescent DNA Through Enzymatic Incorporation of a Highly Emissive Deoxyguanosine Analogue,” RSC Advances 4 (2014): 31341–31344, 10.1039/C4RA05678G. [DOI] [Google Scholar]
- 37. McCoy L. S., Shin D., and Tor Y., “Isomorphic Emissive GTP Surrogate Facilitates Initiation and Elongation of In Vitro Transcription Reactions,” Journal of the American Chemical Society 136 (2014): 15176–15184, 10.1021/ja5039227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Lyon S. and Gopalan V., “A T7 RNA Polymerase Mutant Enhances the Yield of 5'‐Thienoguanosine‐Initiated RNAs,” ChemBioChem 19 (2018): 142–146, 10.1002/cbic.201700538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Li Y., Fin A., McCoy L., and Tor Y., “Polymerase‐Mediated Site‐Specific Incorporation of a Synthetic Fluorescent Isomorphic G Surrogate Into RNA,” Angewandte Chemie International Edition 56 (2017): 1303–1307, 10.1002/anie.201609327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Park S., Otomo H., Zheng L., and Sugiyama H., “Highly Emissive Deoxyguanosine Analogue Capable of Direct Visualization of B‐Z Transition,” Chemical Communications 50 (2014): 1573–1575, 10.1039/c3cc48297a. [DOI] [PubMed] [Google Scholar]
- 41. Kilin V., Gavvala K., Barthes N. P., et al., “Dynamics of Methylated Cytosine Flipping by UHRF1,” Journal of the American Chemical Society 139 (2017): 2520–2528, 10.1021/jacs.7b00154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Han J. H., Park S., Hashiya F., and Sugiyama H., “Approach to the Investigation of Nucleosome Structure by Using the Highly Emissive Nucleobase thdG–tC FRET Pair,” Chemistry – A European Journal 24 (2018): 17091–17095, 10.1002/chem.201803382. [DOI] [PubMed] [Google Scholar]
- 43. Sinkeldam R. W., McCoy L. S., Shin D., and Tor Y., “Enzymatic Interconversion of Isomorphic Fluorescent Nucleosides: Adenosine Deaminase Transforms an Adenosine Analogue Into an Inosine Analogue,” Angewandte Chemie International Edition 52 (2013): 14026–14030, 10.1002/anie.201307064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Mizrahi R. A., Shin D., Sinkeldam R. W., et al., “A Fluorescent Adenosine Analogue as a Substrate for an A‐to‐I RNA Editing Enzyme,” Angewandte Chemie International Edition 54 (2015): 8713–8716, 10.1002/anie.201502070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Rovira A. R., Fin A., and Tor Y., “Chemical Mutagenesis of an Emissive RNA Alphabet,” Journal of the American Chemical Society 137 (2015): 14602–14605, 10.1021/jacs.5b10420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Rovira A. R., Fin A., and Tor Y., “Expanding a Fluorescent RNA Alphabet: Synthesis, Photophysics and Utility of Isothiazole‐Derived Purine Nucleoside Surrogates,” Chemical Science 8 (2017): 2983–2993, 10.1039/C6SC05354H. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Rovira A. R., Fin A., and Tor Y., “Emissive Synthetic Cofactors: An Isomorphic, Isofunctional, and Responsive NAD(+) Analogue,” Journal of the American Chemical Society 139 (2017): 15556–15559, 10.1021/jacs.7b05852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Halle F., Fin A., Rovira A. R., and Tor Y., “Emissive Synthetic Cofactors: Enzymatic Interconversions of (tz) A Analogues of ATP, NAD(+), NADH, NADP(+), and NADPH,” Angewandte Chemie International Edition 57 (2018): 1087–1090, 10.1002/anie.201711935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Feldmann J., Li Y., and Tor Y., “Emissive Synthetic Cofactors: A Highly Responsive NAD(+) Analogue Reveals Biomolecular Recognition Features,” Chemistry 25 (2019): 4379–4389, 10.1002/chem.201805520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Ludford P. T. 3rd, Li Y., Yang S., and Tor Y., “Cytidine Deaminase Can Deaminate Fused Pyrimidine Ribonucleosides,” Organic & Biomolecular Chemistry 19 (2021): 6237–6243, 10.1039/D1OB00705J. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Cong D., Li Y., Ludford P. T. 3rd, and Tor Y., “Isomorphic Fluorescent Nucleosides Facilitate Real‐Time Monitoring of RNA Depurination by Ribosome Inactivating Proteins,” Chemistry 28 (2022): e202200994, 10.1002/chem.202200994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Sholokh M., Sharma R., Shin D., et al., “Conquering 2‐Aminopurine's Deficiencies: Highly Emissive Isomorphic Guanosine Surrogate Faithfully Monitors Guanosine Conformation and Dynamics in DNA,” Journal of the American Chemical Society 137 (2015): 3185–3188, 10.1021/ja513107r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Chawla M., Poater A., Oliva R., and Cavallo L., “Structural and Energetic Characterization of the Emissive RNA Alphabet Based on the Isothiazolo[4,3‐d]pyrimidine Heterocycle Core,” Physical Chemistry Chemical Physics 18 (2016): 18045–18053, 10.1039/C6CP03268K. [DOI] [PubMed] [Google Scholar]
- 54. Dziuba D., Didier P., Ciaco S., Barth A., Seidel C. A. M., and Mély Y., “Fundamental Photophysics of Isomorphic and Expanded Fluorescent Nucleoside Analogues,” Chemical Society Reviews 50 (2021): 7062–7107, 10.1039/D1CS00194A. [DOI] [PubMed] [Google Scholar]
- 55. Seidel C. A. M., Schulz A., and Sauer M. H. M., “Nucleobase‐Specific Quenching of Fluorescent Dyes. 1. Nucleobase One‐Electron Redox Potentials and Their Correlation With Static and Dynamic Quenching Efficiencies,” Journal of Physical Chemistry 100 (1996): 5541–5553, 10.1021/jp951507c. [DOI] [Google Scholar]
- 56. Kuchlyan J., Martinez‐Fernandez L., Mori M., et al., “What Makes Thienoguanosine an Outstanding Fluorescent DNA Probe?,” Journal of the American Chemical Society 142 (2020): 16999–17014, 10.1021/jacs.0c06165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Tkach O., Martinez‐Fernandez L., Ruiz‐Lera A. E., et al., “Exploring Excited‐State Proton Transfer Reactions in Isothiazologuanosine, an Isofunctional Fluorescent Analogue of Guanosine,” Physical Chemistry Chemical Physics 27 (2025): 19820–19836, 10.1039/D5CP02642C. [DOI] [PubMed] [Google Scholar]
- 58. Santoro S. W. and Joyce G. F., “A General Purpose RNA‐Cleaving DNA Enzyme,” PNAS 94 (1997): 4262–4266, 10.1073/pnas.94.9.4262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Schlosser K., Gu J., Sule L., and Li Y., “Sequence‐Function Relationships Provide New Insight Into the Cleavage Site Selectivity of the 8–17 RNA‐Cleaving Deoxyribozyme,” Nucleic Acids Research 36 (2008): 1472–1481, 10.1093/nar/gkm1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Scheitl C. P. M., Ghaem Maghami M., Lenz A. K., and Hobartner C., “Site‐Specific RNA Methylation by a Methyltransferase Ribozyme,” Nature 587 (2020): 663–667, 10.1038/s41586-020-2854-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Scheitl C. P. M., Mieczkowski M., Schindelin H., and Hobartner C., “Structure and Mechanism of the Methyltransferase Ribozyme MTR1,” Nature Chemical Biology 18 (2022): 547–555, 10.1038/s41589-022-00976-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Wawrzyniak‐Turek K. and Höbartner C., “Enzymatic Combinatorial Nucleoside Deletion Scanning Mutagenesis of Functional RNA,” Chemical Communications 50 (2014): 10937–10940, 10.1039/C4CC04719B. [DOI] [PubMed] [Google Scholar]
- 63. Ghazzali M., Khattab S. A. N., Elnakady Y. A., Al‐Mekhlafi F. A., Al‐Farhad K., and El‐Faham A., “Synthesis, Structure, Theoretical Calculations and Biological Activity of Sulfonate Active Ester New Derivatives,” Journal of Molecular Structure 1046 (2013): 147–152, 10.1016/j.molstruc.2013.04.025. [DOI] [Google Scholar]
- 64. Steinmetzger C., Bäuerlein C., and Höbartner C., “Supramolecular Fluorescence Resonance Energy Transfer in Nucleobase‐Modified Fluorogenic RNA Aptamers,” Angewandte Chemie International Edition 59 (2020): 6760–6764, 10.1002/anie.201916707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Neese F., “Software Update: The ORCA Program System‐Version 6.0,” WIREs Computational Molecular Science 15 (2025): e70019, 10.1002/wcms.70019. [DOI] [Google Scholar]
- 66. Neese F., Wennmohs F., Becker U., and Riplinger C., “The ORCA Quantum Chemistry Program Package,” Journal of Chemical Physics 152 (2020): 224108, 10.1063/5.0004608. [DOI] [PubMed] [Google Scholar]
- 67. Lin Y. S., Li G. D., Mao S. P., and Chai J. D., “Long‐Range Corrected Hybrid Density Functionals With Improved Dispersion Corrections,” Journal of Chemical Theory and Computation 9 (2013): 263–272, 10.1021/ct300715s. [DOI] [PubMed] [Google Scholar]
- 68. Weigend F. and Ahlrichs R., “Balanced Basis Sets of Split Valence, Triple Zeta Valence and Quadruple Zeta Valence Quality for H to Rn: Design and Assessment of Accuracy,” Physical Chemistry Chemical Physics 7 (2005): 3297–3305, 10.1039/b508541a. [DOI] [PubMed] [Google Scholar]
- 69. Rappoport D. and Furche F., “Property‐Optimized Gaussian Basis Sets for Molecular Response Calculations,” Journal of Chemical Physics 133 (2010): 134105, 10.1063/1.3484283. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
The authors have cited additional references within the Supporting Information [62, 63, 64, 65, 66, 67, 68, 69].Supporting File: anie74695‐sup‐0001‐SuppMat.docx.
Data Availability Statement
The data that supports the findings of this study are available in the Supporting information of this article.
